# Boston Scientific Corporation (BSX) — Q3-2023 Earnings Results

**Report date:** 2023-10-26 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q3-2023

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 0.42%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.50 | N/A | +4.82% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's performance. They acknowledged market challenges but emphasized their commitment to future growth.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They highlighted ongoing challenges in the market but remain focused on long-term growth.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Boston Scientific's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.42%, which may suggest investor concerns about the lack of revenue information and overall market conditions. The cautious tone from management may also contribute to the stock's downward movement.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q3-2023_